1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Anaphylaxis Treatment Market - By Medication Type
1.3.2 Anaphylaxis Treatment Market - By Route of Administration
1.3.3 Anaphylaxis Treatment Market - By Allergy Type
1.3.4 Anaphylaxis Treatment Market - By Distribution Channel
1.3.5 North America Anaphylaxis Treatment Market - By Country

2. North America Anaphylaxis Treatment Market - Key Takeaways

3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research

4. North America Anaphylaxis Treatment Market - Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 Anaphylaxis Treatment Market- North America PEST Analysis
4.3 Expert Opinion

5. North America Anaphylaxis Treatment Market - Key Market Dynamics
5.1 Market Drivers
5.1.1 Rising Incidence of Anaphylaxis
5.1.2 Recent Approvals for Epinephrine
5.2 Market Restraints
5.2.1 Poor Access to Epinephrine Auto-Injectors in Low-Income Countries
5.3 Market Opportunities
5.3.1 Rise in Cases of Allergies Post Administration of COVID-19 Vaccines
5.4 Future Trends
5.4.1 Novel Drug Delivery Systems
5.5 Impact Analysis

6. Anaphylaxis Treatment Market - North America Analysis
6.1 North America Anaphylaxis Treatment Market Revenue Forecasts and Analysis

7. North America Anaphylaxis Treatment Market Analysis and Forecasts To 2028 - By Medication Type
7.1 Overview
7.2 Anaphylaxis Treatment Market Revenue Share, by Medication Type (2020 and 2028)
7.3 Epinephrine
7.3.1 Overview
7.3.2 Epinephrine: Anaphylaxis Treatment Market - Revenue and Forecast to 2028 (US$ Million)
7.4 Antihistamines
7.4.1 Overview
7.4.2 Antihistamines: Anaphylaxis Treatment Market - Revenue and Forecast to 2028 (US$ Million)
7.5 Steroids
7.5.1 Overview
7.5.2 Steroids: Anaphylaxis Treatment Market - Revenue and Forecast to 2028 (US$ Million)
7.6 Beta-Agonist
7.6.1 Overview
7.6.2 Beta-Agonist: Anaphylaxis Treatment Market - Revenue and Forecast to 2028 (US$ Million)
7.7 Others
7.7.1 Overview
7.7.2 Others: Anaphylaxis Treatment Market - Revenue and Forecast to 2028 (US$ Million)

8. Anaphylaxis Treatment Market Analysis - By Route of Administration
8.1 Overview
8.2 Anaphylaxis Treatment Market Revenue Share, by Route of Administration (2020 and 2028)
8.3 Oral
8.3.1 Overview
8.3.2 Oral: Anaphylaxis Treatment Market - Revenue and Forecast to 2028 (US$ Million)
8.4 Parenteral
8.4.1 Overview
8.4.2 Parenteral: Anaphylaxis Treatment Market - Revenue and Forecast to 2028 (US$ Million)
8.5 Others
8.5.1 Overview
8.5.2 Others: Anaphylaxis Treatment Market - Revenue and Forecast to 2028 (US$ Million)

9. North America Anaphylaxis Treatment Market Analysis and Forecasts To 2028 - By Allergy Type
9.1 Overview
9.2 Anaphylaxis Treatment Market Share, by Allergy Type, 2020 and 2028, (%)
9.3 Food Allergy
9.3.1 Overview
9.3.2 Food Allergy: Anaphylaxis Treatment Market - Revenue and Forecast to 2028 (US$ Million)
9.4 Medications
9.4.1 Overview
9.4.2 Medications: Anaphylaxis Treatment Market - Revenue and Forecast to 2028 (US$ Million)
9.5 Insect Stings
9.5.1 Overview
9.5.2 Insect Stings: Anaphylaxis Treatment Market - Revenue and Forecast to 2028 (US$ Million)
9.6 Others
9.6.1 Overview
9.6.2 Others: Anaphylaxis Treatment Market - Revenue and Forecast to 2028 (US$ Million)

10. North America Anaphylaxis Treatment Market Analysis and Forecasts to 2028- By Distribution Channel
10.1 Overview
10.2 Anaphylaxis Treatment Market, by Distribution Channel, 2020 and 2028 (%)
10.3 Retail Sales
10.3.1 Overview
10.3.2 Retail Sales: Anaphylaxis Treatment Market - Revenue and Forecast to 2028 (US$ Mn)
10.4 Hospital Pharmacies
10.4.1 Overview
10.4.2 Hospital Pharmacies: Anaphylaxis Treatment Market - Revenue and Forecast to 2028 (US$ Mn)
10.5 Others
10.5.1 Overview
10.5.2 Others: Anaphylaxis Treatment Market, Revenue and Forecast to 2028 (US$ Mn)

11. Anaphylaxis Treatment Market Revenue and Forecasts to 2028 - Geographical Analysis
11.1 North America: Anaphylaxis Treatment Market
11.1.1 Overview
11.1.2 North America: Anaphylaxis Treatment Market, by Country, 2020 & 2028 (%)
11.1.2.1 US: Anaphylaxis Treatment Market - Revenue and Forecast to 2028 (USD Million)
11.1.2.1.1 US: Anaphylaxis Treatment Market - Revenue and Forecast to 2028 (USD Million)
11.1.2.1.2 US: Anaphylaxis Treatment Market, by Medication Type, 2019-2028 (USD Million)
11.1.2.1.3 US: Epinephrine Treatment Market by Route of Administration, 2019-2028 (USD Million)
11.1.2.1.4 US: Others Treatment Market by Route of Administration, 2019-2028 (USD Million)
11.1.2.1.5 US: Anaphylaxis Treatment Market, by Allergy Type, 2019-2028 (USD Million)
11.1.2.1.6 US: Anaphylaxis Treatment Market, by Distribution Channel, 2019-2028 (USD Million)
11.1.2.2 Canada: Anaphylaxis Treatment Market - Revenue and Forecast to 2028 (USD Million)
11.1.2.2.1 Canada: Anaphylaxis Treatment Market - Revenue and Forecast to 2028 (USD Million)
11.1.2.2.2 Canada: Anaphylaxis Treatment Market, by Medication Type, 2019-2028 (USD Million)
11.1.2.2.3 Canada: Epinephrine Treatment Market, by Route of Administration, 2019-2028 (USD Million)
11.1.2.2.4 Canada: Others Treatment Market, by Route of Administration, 2019-2028 (USD Million)
11.1.2.2.5 Canada: Anaphylaxis Treatment Market, by Allergy Type, 2019-2028 (USD Million)
11.1.2.2.6 Canada: Anaphylaxis Treatment Market, by Distribution Channel, 2019-2028 (USD Million)
11.1.2.3 Mexico: Anaphylaxis Treatment Market - Revenue and Forecast to 2028 (USD Million)
11.1.2.3.1 Mexico: Anaphylaxis Treatment Market - Revenue and Forecast to 2028 (USD Million)
11.1.2.3.2 Mexico: Anaphylaxis Treatment Market, by Medication Type, 2019-2028 (USD Million)
11.1.2.3.3 Mexico: Anaphylaxis Treatment Market, by Route of Administration, 2019-2028 (USD Million)
11.1.2.3.4 Mexico: Anaphylaxis Treatment Market, by Route of Administration, 2019-2028 (USD Million)
11.1.2.3.5 Mexico: Anaphylaxis Treatment Market, by Allergy Type, 2019-2028 (USD Million)
11.1.2.3.6 Mexico: Anaphylaxis Treatment Market, by Distribution Channel, 2019-2028 (USD Million)

12. Impact Of COVID-19 Pandemic on North America Anaphylaxis Treatment Market
12.1 North America: Impact Assessment of COVID-19 Pandemic

13. Industry Landscape
13.1 Overview
13.2 Growth Strategies Done by the Companies in the Market, (%)
13.3 Organic Developments
13.3.1 Overview
13.4 Inorganic Developments
13.4.1 Overview

14. COMPANY PROFILES
14.1 Abbott
14.1.1 Key Facts
14.1.2 Business Description
14.1.3 Products and Services
14.1.4 Financial Overview
14.1.5 SWOT Analysis
14.1.6 Key Developments
14.2 Adamis Pharmaceuticals Corporation
14.2.1 Key Facts
14.2.2 Business Description
14.2.3 Products and Services
14.2.4 Financial Overview
14.2.5 SWOT Analysis
14.2.6 Key Developments
14.3 ALK-Abelló A/S
14.3.1 Key Facts
14.3.2 Business Description
14.3.3 Products and Services
14.3.4 Financial Overview
14.3.5 SWOT Analysis
14.3.6 Key Developments
14.4 Amneal Pharmaceuticals, Inc.
14.4.1 Key Facts
14.4.2 Business Description
14.4.3 Products and Services
14.4.4 Financial Overview
14.4.5 SWOT Analysis
14.4.6 Key Developments
14.5 GlaxoSmithKline plc.
14.5.1 Key Facts
14.5.2 Business Description
14.5.3 Products and Services
14.5.4 Financial Overview
14.5.5 SWOT Analysis
14.5.6 Key Developments
14.6 Merck & Co., Inc.
14.6.1 Key Facts
14.6.2 Business Description
14.6.3 Products and Services
14.6.4 Financial Overview
14.6.5 SWOT Analysis
14.6.6 Key Developments
14.7 MYLAN N.V.
14.7.1 Key Facts
14.7.2 Business Description
14.7.3 roducts and Services
14.7.4 Financial Overview
14.7.5 SWOT Analysis
14.7.6 Key Developments
14.8 Pfizer Inc.
14.8.1 Key Facts
14.8.2 Business Description
14.8.3 Products and Services
14.8.4 Financial Overview
14.8.5 SWOT Analysis
14.8.6 Key Developments
14.9 TEVA PHARMACEUTICAL INDUSTRIES LTD
14.9.1 Key Facts
14.9.2 Business Description
14.9.3 Products and Services
14.9.4 Financial Overview
14.9.5 SWOT Analysis
14.9.6 Key Developments

15. Appendix
15.1 About the Insight Partners
15.2 Glossary of Terms

Figure 1. Anaphylaxis Treatment Market Segmentation
Figure 2. North America Anaphylaxis Treatment Market Overview
Figure 3. Epinephrine Segment Held Largest Share of Medication Type in Anaphylaxis Treatment Market
Figure 4. US is Expected to Show Remarkable Growth During the Forecast Period
Figure 5. Anaphylaxis Treatment Market - North America PEST Analysis
Figure 6. Anaphylaxis Treatment Market Impact Analysis of Driver and Restraints
Figure 7. North America Anaphylaxis Treatment Market - Revenue Forecasts and Analysis - 2020- 2028
Figure 8. Anaphylaxis Treatment Market Revenue Share, by Medication Type (2020 and 2028)
Figure 9. Epinephrine: Anaphylaxis Treatment Market - Revenue and Forecast to 2028 (US$ Million)
Figure 10. Antihistamines: Anaphylaxis Treatment Market - Revenue and Forecast to 2028 (US$ Million)
Figure 11. Steroids: Anaphylaxis Treatment Market - Revenue and Forecast to 2028 (US$ Million)
Figure 12. Beta-Agonist: Anaphylaxis Treatment Market - Revenue and Forecast to 2028 (US$ Million)
Figure 13. Others: Anaphylaxis Treatment Market - Revenue and Forecast to 2028 (US$ Million)
Figure 14. Anaphylaxis Treatment Market Revenue Share, Route of Administration (2020 and 2028)
Figure 15. Oral: Anaphylaxis Treatment Market - Revenue and Forecast to 2028 (US$ Million)
Figure 16. Parenteral: Anaphylaxis Treatment Market - Revenue and Forecast to 2028 (US$ Million)
Figure 17. Others: Anaphylaxis Treatment Market - Revenue and Forecast to 2028 (US$ Million)
Figure 18. Anaphylaxis Treatment Market Share, by Allergy Type, 2020 and 2028 (%)
Figure 19. Food Allergy: Anaphylaxis Treatment Market - Revenue and Forecast to 2028 (US$ Million)
Figure 20. Medications: Anaphylaxis Treatment Market - Revenue and Forecast to 2028 (US$ Million)
Figure 21. Insect Stings: Anaphylaxis Treatment Market - Revenue and Forecast to 2028 (US$ Million)
Figure 22. Others: Anaphylaxis Treatment Market - Revenue and Forecast to 2028 (US$ Million)
Figure 23. Anaphylaxis Treatment Market, by Distribution Channel, 2020 and 2028 (%)
Figure 24. Retail Sales: Anaphylaxis Treatment Market - Revenue and Forecast to 2028 (US$ Mn)
Figure 25. Hospital Pharmacies: Anaphylaxis Treatment Market - Revenue and Forecast to 2028 (US$ Mn)
Figure 26. Others: Anaphylaxis Treatment Market, Revenue and Forecast to 2028 (US$ Mn)
Figure 27. North America: Anaphylaxis Treatment Market, by Key Country - Revenue (2020) (USD Million)
Figure 28. North America: Anaphylaxis Treatment Market, by Country, 2020 & 2028 (%)
Figure 29. US: Anaphylaxis Treatment Market - Revenue and Forecast to 2028 (USD Million)
Figure 30. Canada: Anaphylaxis Treatment Market - Revenue and Forecast to 2028 (USD Million)
Figure 31. Mexico: Anaphylaxis Treatment Market - Revenue and Forecast to 2028 (USD Million)
Figure 32. Impact of COVID-19 Pandemic in North American Country Markets
Figure 33. Growth Strategies Done by the Companies in the Market, (%)

Table 1. US: Anaphylaxis Treatment Market, by Medication Type - Revenue and Forecast to 2028 (USD Million)
Table 2. US: Epinephrine Treatment Market by Route of Administration - Revenue and Forecast to 2028 (USD Million)
Table 3. US: Others Treatment Market by Route of Administration - Revenue and Forecast to 2028 (USD Million)
Table 4. US: Anaphylaxis Treatment Market, by Allergy Type - Revenue and Forecast to 2028 (USD Million)
Table 5. US Anaphylaxis Treatment Market, by Distribution Channel - Revenue and Forecast to 2028 (USD Million)
Table 6. Canada: Anaphylaxis Treatment Market, by Medication Type - Revenue and Forecast to 2028 (USD Million)
Table 7. Canada: Epinephrine Treatment Market, by Route of Administration - Revenue and Forecast to 2028 (USD Million)
Table 8. Canada: Others Treatment Market, by Route of Administration - Revenue and Forecast to 2028 (USD Million)
Table 9. Canada: Anaphylaxis Treatment Market, by Allergy Type - Revenue and Forecast to 2028 (USD Million)
Table 10. Canada Anaphylaxis Treatment Market, by Distribution Channel - Revenue and Forecast to 2028 (USD Million)
Table 11. Mexico: Anaphylaxis Treatment Market, by Medication Type - Revenue and Forecast to 2028 (USD Million)
Table 12. Mexico: Anaphylaxis Treatment Market, by Route of Administration - Revenue and Forecast to 2028 (USD Million)
Table 13. Mexico: Anaphylaxis Treatment Market, by Route of Administration - Revenue and Forecast to 2028 (USD Million)
Table 14. Mexico: Anaphylaxis Treatment Market, by Allergy Type - Revenue and Forecast to 2028 (USD Million)
Table 15. Mexico Anaphylaxis Treatment Market, by Distribution Channel - Revenue and Forecast to 2028 (USD Million)
Table 16. Organic Developments Done by Companies
Table 17. Inorganic Developments Done by Companies
Table 18. Glossary of Terms, Anaphylaxis Treatment Market

The List of Companies - North America Anaphylaxis Treatment Market

? Amneal Pharmaceuticals Inc.
? Mylan N.V.
? Adamis Pharmaceutical Corporation
? Abbott
? Pfizer Inc.
? Glaxosmithkline Plc.,
? Merck And Co., Inc.
? Teva Pharmaceutical Industries Ltd.        
? ALK-ABELLó